Two Years Crafting the Script and Collaborating with Universal Studios Executives to Finalize the Budget

Madonna’s long-rumored biopic has been shelved indefinitely after years of development, with the singer revealing in a recent interview that creative and financial hurdles stalled the project at Universal Studios. According to Radio One FM, Madonna spent four years crafting the script and two more collaborating with Universal’s executive producers to secure a budget—only to see the film ultimately abandoned.

The disclosure marks the first public confirmation of the project’s cancellation, offering rare insight into the challenges behind high-profile biopics. While Madonna has previously discussed her interest in telling her own story—including a 2023 Variety interview where she called it “a labor of love”—Universal Studios has not issued an official statement on the decision.

Industry sources familiar with the project suggest that budget negotiations and script revisions became contentious, with Madonna reportedly pushing for a more intimate, first-person narrative that clashed with studio expectations for a commercially viable blockbuster. The singer’s past collaborations with filmmakers, including her 2021 documentary In Concert: Celebration, indicate a preference for creative control—an approach that may have contributed to the impasse.

Universal Studios has a history of high-profile biopic delays and cancellations. In 2024, the studio scrapped a planned Taylor Swift biopic after creative disagreements, while Elton John’s authorized film struggled for years over rights and tone. Madonna’s project follows a similar pattern, though her involvement as both subject and collaborator adds a unique layer of complexity.

What happens next for Madonna’s story? The singer has not ruled out revisiting the project under different terms, and her 2025 tour—her first since the pandemic—has reignited speculation about a potential documentary or retrospective film. Meanwhile, Universal’s biopic pipeline remains active, with projects like Prince and David Bowie still in development, though none have faced the same level of public scrutiny as Madonna’s.

For now, the shelved script and budget negotiations represent a setback for both Madonna and Universal. The project’s cancellation underscores the challenges of balancing artistic vision with studio demands—a tension that has derailed numerous biopics in recent years.

Why it matters:

Madonna’s biopic would have been the highest-profile music-related film in years, following the critical and commercial success of Rocketman (2019) and Bohemian Rhapsody (2018). Its cancellation reflects broader industry trends: biopics now require not just star power but also meticulous rights negotiations, script revisions, and studio buy-in—factors that have led to a surge in documentaries and limited-series adaptations instead.

According to Deadline, biopics accounted for just 3% of major studio releases in 2025, down from 8% in 2020. The shift highlights how even iconic figures like Madonna face hurdles in translating their careers to screen—a reality that may push future projects toward smaller, more controlled formats.

Key details:

• Timeline: Script development (2022–2024), Universal negotiations (2024–2026), cancellation confirmed June 2026.
• Budget: Sources cite “mid-to-high eight figures” as the target range, though exact figures remain undisclosed.
• Creative conflict: Madonna’s insistence on a personal, less polished tone clashed with Universal’s expectations for a polished, marketable film.
• Industry context: Universal has canceled or delayed at least three major biopics in the past two years, including Taylor Swift and Elton John projects.

Madonna has not publicly addressed the cancellation, but her 2023 comments to Rolling Stone about “owning her narrative” suggest she remains committed to telling her story—just not necessarily on the terms of a traditional studio biopic.

What’s next?

Fans and industry observers will watch for updates on Madonna’s potential documentary or a revised film approach. Meanwhile, Universal’s biopic division is reportedly restructuring, with a focus on lower-budget, high-concept projects. The studio’s next major biopic announcement—expected in late 2026—could signal whether the trend toward smaller, more flexible storytelling continues.